Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 1
1996 1
1999 1
2001 2
2002 2
2003 1
2005 1
2007 2
2008 4
2009 5
2010 3
2011 3
2012 1
2013 1
2014 3
2015 2
2016 2
2017 2
2018 2
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.
Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJB, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JMM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R. Baumert BG, et al. Among authors: Rees J. Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27. Lancet Oncol. 2016. PMID: 27686946 Free PMC article. Clinical Trial.
BACKGROUND: Outcome of low-grade glioma (WHO grade II) is highly variable, reflecting molecular heterogeneity of the disease. ...INTERPRETATION: Overall, there was no significant difference in progression-free survival in patients with low-grade glioma when treated …
BACKGROUND: Outcome of low-grade glioma (WHO grade II) is highly variable, reflecting molecular heterogeneity of the disease. ...INTE …
Advanced MRI Techniques in the Monitoring of Treatment of Gliomas.
Hyare H, Thust S, Rees J. Hyare H, et al. Among authors: Rees J. Curr Treat Options Neurol. 2017 Mar;19(3):11. doi: 10.1007/s11940-017-0445-6. Curr Treat Options Neurol. 2017. PMID: 28349351 Review.
The impact of route of diagnosis on survival in patients with glioblastoma.
Kosmin M, Solda' F, Wilson E, Kitchen N, Rees J, Fersht N. Kosmin M, et al. Among authors: Rees J. Br J Neurosurg. 2018 Dec;32(6):628-630. doi: 10.1080/02688697.2018.1436693. Epub 2018 Feb 9. Br J Neurosurg. 2018. PMID: 29426231
Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.
Thust SC, Hassanein S, Bisdas S, Rees JH, Hyare H, Maynard JA, Brandner S, Tur C, Jäger HR, Yousry TA, Mancini L. Thust SC, et al. Among authors: Rees JH. Eur Radiol. 2018 Sep;28(9):3779-3788. doi: 10.1007/s00330-018-5351-0. Epub 2018 Mar 23. Eur Radiol. 2018. PMID: 29572636 Free PMC article.
CONCLUSIONS: ADC measurements can support the distinction of glioma subtypes. Volumetric and two-dimensional measurements yielded similar results in this study. KEY POINTS: • Diffusion-weighted MRI aids the identification of non-gadolinium-enhancing malignant gliomas
CONCLUSIONS: ADC measurements can support the distinction of glioma subtypes. Volumetric and two-dimensional measurements yielded sim …
Low-grade gliomas in adults.
Rees JH. Rees JH. Curr Opin Neurol. 2002 Dec;15(6):657-61. doi: 10.1097/01.wco.0000044760.39452.71. Curr Opin Neurol. 2002. PMID: 12447102 Review.
PURPOSE OF REVIEW: This paper aims to summarize the current thinking about the management of adult supratentorial low-grade gliomas. ...SUMMARY: The best management of low-grade gliomas is still unknown but advances in molecular genetics and imaging are improving ou …
PURPOSE OF REVIEW: This paper aims to summarize the current thinking about the management of adult supratentorial low-grade gliomas. …
Diagnosis and treatment in neuro-oncology: an oncological perspective.
Rees JH. Rees JH. Br J Radiol. 2011 Dec;84 Spec No 2(Spec Iss 2):S82-9. doi: 10.1259/bjr/18061999. Br J Radiol. 2011. PMID: 22433832 Free PMC article. Review.
Gliomas account for over 60% of primary brain tumours and usually present with one or more symptoms of raised intracranial pressure, progressive neurological deficit, seizures, focal or global cognitive decline. ...Conversely imaging may suggest lack of efficacy of treatme
Gliomas account for over 60% of primary brain tumours and usually present with one or more symptoms of raised intracranial pressure,
Quantitative imaging biomarkers in neuro-oncology.
Waldman AD, Jackson A, Price SJ, Clark CA, Booth TC, Auer DP, Tofts PS, Collins DJ, Leach MO, Rees JH; National Cancer Research Institute Brain Tumour Imaging Subgroup. Waldman AD, et al. Among authors: Rees JH. Nat Rev Clin Oncol. 2009 Aug;6(8):445-54. doi: 10.1038/nrclinonc.2009.92. Epub 2009 Jun 23. Nat Rev Clin Oncol. 2009. PMID: 19546864 Review.
Seizure outcomes and survival in adult low-grade glioma over 11 years: living longer and better.
Solomons MR, Jaunmuktane Z, Weil RS, El-Hassan T, Brandner S, Rees JH. Solomons MR, et al. Among authors: Rees JH. Neurooncol Pract. 2020 Mar;7(2):196-201. doi: 10.1093/nop/npz056. Epub 2019 Nov 21. Neurooncol Pract. 2020. PMID: 32206321
BACKGROUND: There has been a trend toward earlier and more aggressive resection for low-grade gliomas (LGGs). This study set out to compare seizure control and survival of adults with LGG seen in the same neuro-oncology clinic over 11 years and to determine whether a chang …
BACKGROUND: There has been a trend toward earlier and more aggressive resection for low-grade gliomas (LGGs). This study set out to c …
Quantitative magnetisation transfer imaging in glioma: preliminary results.
Tozer DJ, Rees JH, Benton CE, Waldman AD, Jäger HR, Tofts PS. Tozer DJ, et al. Among authors: Rees JH. NMR Biomed. 2011 Jun;24(5):492-8. doi: 10.1002/nbm.1614. Epub 2010 Oct 19. NMR Biomed. 2011. PMID: 20960580
It has been used in multiple sclerosis and Alzheimer's disease, and has shown changes in some of the parameters, particularly the bound proton fraction. The purpose of this pilot study was to assess whether qMTI could distinguish between gliomas and normal brain tis …
It has been used in multiple sclerosis and Alzheimer's disease, and has shown changes in some of the parameters, particularly the bou …
36 results
Jump to page
Feedback